ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,770.20
      0.55%
      US Tech 100
      19,472.40
      -1.01%
      Dow Jones
      42,801.72
      0.00%
      Brent Oil
      70.505
      1.12%
      Bitcoin
      82,489.96
      2.36%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Caladrius Biosciences Inc (CLBS) Quote

      Caladrius Biosciences Inc

      Caladrius Biosciences Inc (CLBS)

      Celebrus Technologies Plc
      0.4264
      0.00
      (0.00%)
      Closed March 07 4:00PM
      Delayed by 15 minutes
      0.4264
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.4264
      Bid
      0.4264
      Ask
      0.43
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      3.475M
      Previous Close
      0.4264
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      8,150,000
      Dividend Yield
      -
      PE Ratio
      -0.92
      Earnings Per Share (EPS)
      -2.56
      Revenue
      -
      Net Profit
      -20.84M

      About Caladrius Biosciences Inc

      Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the... Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its current product candidates include XOWNA, HONEDRA and CLBS201. Show more

      Sector
      Health & Allied Services,nec
      Industry
      Insurance Carriers, Nec
      Website
      www.caladrius.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2006

      Ask ADVFN Intelligence (AI)

      CLBS Latest News

      More News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      CLBS - Frequently Asked Questions (FAQ)

      What is the current Caladrius Biosciences share price?
      The current share price of Caladrius Biosciences is $ 0.4264
      How many Caladrius Biosciences shares are in issue?
      Caladrius Biosciences has 8,150,000 shares in issue
      What is the market cap of Caladrius Biosciences?
      The market capitalisation of Caladrius Biosciences is USD 3.48M
      What is the 1 year trading range for Caladrius Biosciences share price?
      Caladrius Biosciences has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Caladrius Biosciences?
      The price to earnings ratio of Caladrius Biosciences is -0.92
      What is the reporting currency for Caladrius Biosciences?
      Caladrius Biosciences reports financial results in USD
      What is the latest annual profit for Caladrius Biosciences?
      The latest annual profit of Caladrius Biosciences is USD -20.84M
      What is the registered address of Caladrius Biosciences?
      The registered address for Caladrius Biosciences is 651 N BROAD ST SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19709
      What is the Caladrius Biosciences website address?
      The website address for Caladrius Biosciences is www.caladrius.com
      Which industry sector does Caladrius Biosciences operate in?
      Caladrius Biosciences operates in the INSURANCE CARRIERS, NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RDFNRedfin Corporation
      $ 10.80
      (85.57%)
      		5.21M
      STSSSharps Technology Inc
      $ 0.5177
      (74.49%)
      		68.78M
      CKPTCheckpoint Therapeutics Inc
      $ 4.13
      (67.21%)
      		1.65M
      LGHLWLion Group Holding Ltd
      $ 0.01
      (56.25%)
      		7
      NCSMNCS Multistage Holdings Inc
      $ 34.99
      (37.27%)
      		2
      BTOCAmlogi Holding Corporation
      $ 1.03
      (-36.02%)
      		2
      LEGHLegacy Housing Corporation
      $ 16.48
      (-34.16%)
      		7
      GEOSGeospace Technologies Corporation
      $ 5.33
      (-28.65%)
      		14
      XMTRXometry Inc
      $ 19.01
      (-22.82%)
      		17
      STBXStarBox Group Holdings Ltd
      $ 0.3224
      (-17.33%)
      		396.92k
      STSSSharps Technology Inc
      $ 0.5177
      (74.49%)
      		68.78M
      ICONIcon Energy Corporation
      $ 0.2022
      (19.79%)
      		30.33M
      BTOGBit Origin Ltd
      $ 0.5431
      (-12.40%)
      		26.19M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 10.18
      (-4.50%)
      		7.67M
      RDFNRedfin Corporation
      $ 10.80
      (85.57%)
      		5.21M

      Discussion

      View Full Feed
      Bubae Bubae 6 minutes ago
      Yes, but you make it sound like such a big deal as if real investors are interested in a company with Mexedia's 2024 disaster of a balance sheet. If they were interested they would buy Mexedia's stock that is down 77% YOY, not this stinker. This stock is being used to raise capital for Mexedia, thin
      RDAR
      MartinLutherKing MartinLutherKing 6 minutes ago
      TTX- Stargate has landed on earth 🚀🚀🚀
      RNAZ
      TJG TJG 8 minutes ago
      The accounting firm we currently are using are certified to audit for SEC compliant financials...which is not to say that those in charge can not change them, but they have been working with Affluence for several years. Gonyer is very capable of doing the inhouse portion.. if and when they decide t
      AFFU
      RIGATONI RIGATONI 9 minutes ago
      $1.55 not much to cheer about over the last few weeks, this one did well due to the sector ~Rig
      Tamboo Tamboo 10 minutes ago
      Pre market bla bls negativity 
      GVSI
      willpellel willpellel 11 minutes ago
      Yup, typical PSRU fashion...........keep kicking it forward. Eventually, you MAY be right. And man, are there ever gonna be a bunch of "I told you so"
      PSRU
      capgain capgain 15 minutes ago
      Hey Myth. I'm on a PGA top 20 roll after a slow start lol

      Hit two in a row with the same guy.

      Might try him again this week also. :)
      MartinLutherKing MartinLutherKing 16 minutes ago
      Hold on to your dirty underwears brothers this will be the biggest short squeeze play in its history
      RNAZ
      Zadie420 Zadie420 17 minutes ago
      Sorry for his set back fighting against brain cancer. He is a professor and knowledgeable person but does not know about DCVAX-L and combo trials that extended the life of many patients. Some of the combo trials like DCVax-L + Ploy-ICLC has been around for more than 10 years.

      "While t
      NWBO
      StayHumble StayHumble 17 minutes ago
      per Current Insiders CE0💹KevinLamb💹T0P10 Healthcare innovators💹Forbes wow $UBQU
      https://x.com/CorporateUbqu/status/1802724359762506049
      https://investorshub.advfn.com/uimage/uploads/2025/1/2/amsjgsuckasscurrentlybitch.png
      https://cdn.vox-cdn.com/uploa
      UBQU
      Z06 MAN Z06 MAN 17 minutes ago
      https://www.kraiglabs.com/kraig-biocraft-laboratories-meets-its-target-with-largest-ever-product-batch-of-bam-1-spider-silk-surpassing-entire-2024-output/
      KBLB
      MartinLutherKing MartinLutherKing 18 minutes ago
      It’s the one and only FDA human clinical trials Micro RNA Cancer metastasis trial
      RNAZ
      SC8 SC8 19 minutes ago
      Actually agree with you on the antiparasitics combined with immunotherapy. Very low carb diet should help too to at least buy time (cancer needs sugar or glutamine to grow). But in general, don't think there's an effective chemo option for metastatic melenoma. Radiogel might have a very limited r
      RDGL
      Here Today Here Today 22 minutes ago
      I guess you didn't know about them diluting the Share Count with Warrants being issued. Now current OS is over 4 million shares:

      RNAZ
      Thomas@yahoo Thomas@yahoo 22 minutes ago
      https://www.marijuanamoment.net/coating-dentures-with-cbd-can-help-prevent-oral-infections-government-funded-study-shows/

      https://www.marijuanamoment.net/kentucky-senate-passes-hemp-drinks-bill-with-amendment-regulating-instead-of-banning-them/

      https://www.federalregist
      CVSI
      MartinLutherKing MartinLutherKing 22 minutes ago
      TTX- Nobel breakthrough 🚀🚀🚀🚀🚀🚀
      RNAZ
      Ranb2khz Ranb2khz 22 minutes ago
      Want and Plenty

      “I know both how to have a little, and I know how to have a lot. In any and all circumstances I have learned the secret of being content – whether well fed or hungry, whether in abundance or in need. I am able to do all things through Him [Christ] who strengthens me.”
      silkmaster silkmaster 22 minutes ago
      Once againg KT does not say did they produce 100KG , 500KG, 1Ton or more ....

      "—it is larger than everything we produced throughout all of 2024"

      O.K that is great but numbers....
      KBLB
      Yahsho Yahsho 22 minutes ago
      This is not true in the slightest.

      The current CEO condemns it and he spoke in front of his NIH colleagues about the last management.

      This information is misleading and misinformation. Noted.
      CYDY
      GreenBackClub GreenBackClub 22 minutes ago
      VOIP-PAL.COM, INC. v. T-Mobile US, Inc. et al
      Texas Western District Court
      Judge: Alan D Albright
      Case #: 6:21-cv-00674
      Nature of Suit 830 Property Rights - Patent
      Cause 35:271 Patent Infringement
      Case Filed: Jun 25, 2021
      Terminated: Aug 15, 2024
      VPLM
      IcyGalaxy60 IcyGalaxy60 23 minutes ago
      S&P 500 is making a correction, i think that good times are beginning.
      NBRI
      StayHumble StayHumble 23 minutes ago
      Markets Primed💹Xperts Are ✅JUMBO SHORT✅ $SHMP💹 $10 wow!!
      SHMP
      MartinLutherKing MartinLutherKing 23 minutes ago
      Let’s all hold hands and pray for FDA green light
      RNAZ

      Your Recent History

      NASDAQ
      CLBS
      Caladrius Biosciences
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads